Adam works on the AAV team at Life Edit Therapeutics, aiming to establish an effective process to produce high quality rAAV for use in our gene therapy programs. He has over 10 years of experience in molecular biology and viral vector production.
Prior to joining Life Edit, Adam worked at Precision BioSciences where he developed expertise in AAV production, purification, and characterization. He was also involved in cutting-edge research at Duke University investigating the use of gene editing technology in the treatment of viral disease.
Adam received his B.S. in Microbiology and B.A. in Chemistry from The Ohio State University.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
